General pathology

12345678910111213141516171819202122232425262728293031323334353637383940414243444546474849505152535455565758596061626364656667686970717273747576777879808182838485868788899091929394
Across
  1. 4. the term used to describe an animal that shows atrophy of all the parenchymatous organs and skeletal muscles, serous atrophy of the body fat, and (non-regenerative) anaemia. Usually caused by starvation or chronic debilitating diseases.
  2. 6. a watery exudate containing variable amounts of protein.
  3. 8. small, flat haemorrhages of about one mm in diameter.
  4. 9. a usually spherical structure consisting of purulent exudate encapsulated in a fibrous capsule.
  5. 14. local ( often spherical) accumulations of blood in tissues or organs.
  6. 18. the process by which normal somatic cells are transformed (mutated) into cells that are no longer under the control of the body in which they are growing.
  7. 21. this is cell swelling (osmotic cell odema) following on direct or indirect membrane injury, which may or may not be lethal.
  8. 25. the process of cellular degradation caused by lysosomal enzymes that are released after somatic death.
  9. 27. the physiological decrease in the size of an organ or tissue following completion of a normal function.
  10. 28. the usual type of necrosis in which cell and tissue architecture is retained.
  11. 31. the dissolution of nuclear chromatin following cell death.
  12. 34. the time interval between death and post mortem examination.
  13. 35. refers to variable morphology of the cells constituting a specific neoplasm.
  14. 36. application of a different chemical carcinogen to a sensitised cell, causing it to transform into a pre-neoplastic cell.
  15. 38. the identification of a disease by its name.
  16. 42. the steps by which a normal cell is transformed into a neoplastic cell.
  17. 46. the accumulation of triglycerides in the cytoplasm of a cell.
  18. 47. the black pigment (hydrogen sulphide) formed by the action of saprophytic clostridial bacteria after death
  19. 48. a benign neoplasm of squamous (non-secretory) epithelial cells.
  20. 49. a localized type I hypersensitivity reaction.
  21. 55. the increase in the size of an organ or tissue due to an increase in the size of the constituent cells.
  22. 56. the disintegration of the nucleus into bits of condensed chromatin following cell death.
  23. 57. an exudate containing a large amount of polymerized fibrinogen.
  24. 58. the failure of an embryonal anlage for an organ or tissue to develop (the anlage is present but does not develop).
  25. 59. the type of necrosis in the central nervous system that is associated with softening of the tissues.
  26. 61. the process by which a normal cell in the body is changed into a neoplastic cell in that body.
  27. 62. the development of a lesion and/or a disease in space and time.
  28. 64. the swelling of tissues and organs caused by the presence of excessive serous fluid in the extravascular compartment.
  29. 65. the movement of leucocytes from the capillary lumen into the extracellular matrix.
  30. 67. the cells, fluid and chemicals that pass from the blood vessel lumen into the injured tissue.
  31. 70. the process in which bacteria are coated with c3b, antibody and fibronectin, rendering them more susceptible to phagocytosis.
  32. 75. the increase in the size of an organ or tissue due to an increase in the number of the constituent cells.
  33. 79. the presence of endotoxins in the bloodstream.
  34. 80. necrosis of tissues, usually the distal limbs and ears, mostly because of failure of the blood supply.
  35. 82. the slow, rolling motion of leucocytes on the inside of the capillary wall in the pre-exudative phase of inflammation.
  36. 84. excessive production of the fibrous component of the stroma of a neoplasm.
  37. 85. a benign neoplasm of glandular (secretory) epithelial cells.
  38. 86. a pathological clot in the lumen of a blood or lymph vessel.
  39. 87. the failure of an embryonal anlage to form (the anlage is absent).
  40. 88. the presence of bacteria in the bloodstream.
  41. 89. the presence of a toxin in the boodstream.
  42. 90. an attempt to predict the future course and outcomes of a disease or disease process.
  43. 91. caused by the clinician.
  44. 92. a localised area of ischaemic necrosis in a tissue or organ produced by occlusion of the arterial supply or of the venous drainage.
  45. 93. a detached (?free-floating) physical mass in the lumen of a vessel.
  46. 94. the steps in oncogenesis that lead to the transformation of a pre-neoplastic cell to a neoplastic cell.
Down
  1. 1. an abnormality that arises in living tissue as a result of a loss of homeostasis.
  2. 2. the disorderly differentiation of the cells in a tissue, most often seen in the epidermis of the skin.
  3. 3. the presence of viruses in the bloodstream.
  4. 4. the type of necrosis seen in tuberculosis and caseous lymphadentis in which the necrotic tissue resembles crumbly cheese.
  5. 5. a process in which cells generate energy and metabolites by digesting their own organelles and macromolecules, leading to cell death if nutrients are not received by the cell.
  6. 7. the change in an organ or tissue of a cell from one type of mature cell to another type of mature cell of the same embryonal origin.
  7. 10. the study of disease.
  8. 11. the spread of neoplastic cells from a tumour to a distant organ/tissue.
  9. 12. a process involving the activation of caspases and the bcl2 gene in the cell, leading to cell death via a complex molecular cascade.
  10. 13. directional migration in response to a chemoattractant gradient.
  11. 15. a systemic type I hypersensitivity reaction.
  12. 16. the process of condensation of nuclear chromatin following cell death.
  13. 17. complete repair of injured tissue.
  14. 19. the term used to describe the serous fluid that accumulates in the extravascular compartment.
  15. 20. the presence of toxins in the bloodstream that originate in the intestinal lumen.
  16. 22. the study of lesions in the immune system.
  17. 23. an increased volume of blood in a tissue or organ due to impaired venous drainage of that tissue of organ.
  18. 24. an overgrowth of normal tissue in a location in which it is not normally found.
  19. 26. these are genes that are involved in the expression of the neoplastic phenotype.
  20. 29. the proximate cause of a specific disease.
  21. 30. medium-sized, flat haemorrhages (about 2 to 15 mm diameter).
  22. 32. the failure of a neoplastic cell to differentiate (mature).
  23. 33. the decrease in size of an organ or tissue due to a decrease in the size of the constituent cells (quantitative atrophy) and/or a decrease in the number of cells (numerical atrophy).
  24. 37. incomplete repair of injured tissue, which is replaced by less specialized connective tissue.
  25. 39. sensitisation of a cell to subsquent neoplastic transformation by means of the application of a chemical carcinogen.
  26. 40. the failure of an organ or tissue to develop to its full size.
  27. 41. polypeptide mediatiors secreted by cells in response to a stimulus.
  28. 43. the chemical process induced in adipose tissue by free fatty acids that react with calcium ions to form alkaline salts known as soaps.
  29. 44. a malignant neoplasm arising from an epithelial cell.
  30. 45. an exudate containing a large amount of mucus.
  31. 50. the invasion of the bloodstream by pathogenic bacteria, with multiplication of and toxin production by the bacteria.
  32. 51. a thin membrane covering a mucosal surface, composed of fibrinous exudate, mucus and necrotic and other debris.
  33. 52. of unknown cause.
  34. 53. the post mortem process resulting from the proliferation of saprophytic bacteria originating from the intestinal tract.
  35. 54. a state in which a living organism is not in homeostasis.
  36. 60. this is the establishment of a neoplasm at a new site following the release of tumour cells from a neoplasm into a body cavity.
  37. 63. a specific group of cytokines responsible for the selective attraction of various leukocytes.
  38. 66. tightly packed marginated leucocytes.
  39. 68. an overgrowth of normal tissue in a location in which it is normally found.
  40. 69. a state of dynamic balance of life processes that exists in a healthy living organism.
  41. 71. large flat haemorrhages (greater than about 15 mm diameter).
  42. 72. the reaction of tissues to injury.
  43. 73. the process by which certain cells internalize particles, hydrolyze them and eject the debris.
  44. 74. is the extravasation of blood.
  45. 76. a malignant neoplasm arising from a connective tissue cell.
  46. 77. an increased volume of blood in a tissue or organ due to an increase in blood flow to that tissue or organ.
  47. 78. an extracellular deposit composed of any one of a family of unrelated proteins deposited in a specific physical configuration in a number of tissues and organs in association with a diverse group of diseases.
  48. 81. a process following cell death which involves hydrolytic enzyme release from lysosomes with consequent denaturation and coagulation of the cytoplasmic proteins.
  49. 83. the body’s attempt to replace dead or injured tissue with healthy tissue.